ResMed (NYSE:RMD) Upgraded to “Buy” at StockNews.com

ResMed (NYSE:RMD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. RMD has been the subject of a number of other research reports. Oppenheimer lowered shares of ResMed from an “outperform” rating to a “market perform” rating in […]

Leave a Reply

Your email address will not be published.

Previous post Frequency Electronics (NASDAQ:FEIM) Stock Rating Lowered by StockNews.com
Next post ZEON (ZEON) Trading Down 0.9% Over Last Week